跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AG-RIZATRIPTAN ODT - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AG-RIZATRIPTAN ODT
Authorized
STANDARD
AG-RIZATRIPTAN ODT
angita pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
631e2c1cf6f06ff6
Company
angita pharma inc.
Type
Standard
Approval Details
Approval Id
631e2c1cf6f06ff6
Drug Approval Canada Name
AG-RIZATRIPTAN ODT
Product Name
AG-RIZATRIPTAN ODT
Status
Marketed
Status Date
2020-11-25
Original Market Date
2020-01-27
Din
02492490
Drug Class
Human
Dosage Form
Tablet (Orally Disintegrating)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:32.28
Atc Original
N02CC04 RIZATRIPTAN
Atc Name
n 02 cc 04
Aig Number
0137841002
Company Name
angita pharma inc.
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Active Ingredients
RIZATRIPTAN (RIZATRIPTAN BENZOATE)
10 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
631e2c1cf6f06ff6
Type
Standard
Back to Health Canada Approvals